Paid Clinical Trials in Texas

Texas has 5,347 paid clinical trials enrolling now across cities including Houston, Dallas and San Antonio. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Research sites in Texas include MD Anderson Cancer Center, Baylor College of Medicine and UT Southwestern, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 17, 2026.

Filter results

Filter results

State

City

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

4,652 clinical trials

Get a weekly email when new trials open in Houston, TX.

A Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to Babies With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec

for Muscular Atrophy, Spinal

1 location in Flower Mound

Sponsor: Biogen

Sex: All·Age: 0 Days - 7 Months

Code: NCT07444450·Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

for Systemic Lupus Erythematosus

Sites in Houston, Austin +27 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 70

Code: NCT07430306·Phase 3·Recruiting·Listed Feb 2026

Apply to this trial

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

for Gastric Cancer

Drug: Sonesitatug vedotin

Sites in Houston, Dallas +78 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07431281·Phase 3·Recruiting·Listed Feb 2026

Apply to this trial

A Phase I Study of Pazopanib in Combination With Trabectedin, Ipilimumab and Nivolumab (TraPIN) in Pediatric and Young Adult Patients With Recurrent Soft Tissue Sarcomas

for Soft Tissue Sarcomas

Drug: Ipilimumab

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 1 - 30

Code: NCT07444619·Phase 1·Recruiting·Listed Mar 2026

Apply to this trial

Safety and Efficacy of J147 in Acute Ischemic Stroke

for Acute Ischemic Stroke

Sites in Austin +1 more location

Sponsor: Abrexa Pharmaceuticals, Inc.

Sex: All·Age: 18 - 90

Code: NCT07430917·Phase 2·Recruiting·Listed Feb 2026

Apply to this trial

PREDICTT Clinical Trial: Prospective Evaluation Of Pressure-Enabled Delivery And Alterations In CT-Based Tumor-To-Normal Liver Ratio And Tumor Dose Using The Trinav Infusion System

for Tumor

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT07444645·Recruiting·Listed Mar 2026

Apply to this trial

A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)

for Metastatic Colorectal Cancer

Sites in Houston +2 more locations

Sponsor: Hoffmann-La Roche

Sex: All·Age: 18+

Code: NCT07416552·Phase 1·Recruiting·Listed Feb 2026

Apply to this trial

A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults

for Influenza, Human+COVID-19

Sites in Austin +11 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 65 - 85

Code: NCT07464314·Phase 1·Recruiting·Listed Mar 2026

Apply to this trial

Safety, Pharmacokinetics (PK), and Efficacy of ONC-783 in Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Houston +2 more locations

Sponsor: OncoC4, Inc.

Sex: All·Age: 18+

Code: NCT07408258·Phase 1·Recruiting·Listed Feb 2026

Apply to this trial

First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combination in Adult Participants With Advanced Solid Tumors

for Neoplasms

Sites in San Antonio +1 more location

Sponsor: GlaxoSmithKline

Sex: All·Age: 18+

Code: NCT07438782·Phase 1·Recruiting·Listed Feb 2026

Apply to this trial

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

for Relapsed/Refractory Hematological Malignancies

Sites in Houston +4 more locations

Sponsor: Ascentage Pharma Group Inc.

Sex: All·Age: 18+

Code: NCT07424833·Phase 1·Recruiting·Listed Feb 2026

Apply to this trial

Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design

for Fibromyalgia

Sites in Houston, Dallas +51 more locations

Sponsor: Axsome Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT07398417·Phase 3·Recruiting·Listed Feb 2026

Apply to this trial

A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)

for Relapsed Refractory Multiple Myeloma

Sites in Houston, Dallas +34 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07391657·Phase 3·Recruiting·Listed Feb 2026

Apply to this trial

EEG-Guided Binaural Beat Audio to Reduce Performance-Related Stress and Improve Cognition

for Cognitive Abilities

1 location in Lubbock

Sponsor: Texas Tech University Health Sciences Center

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT07407426·Recruiting·Listed Feb 2026

Apply to this trial

Phase 1 Study Of Izalontamab Brengitecan + Adagrasib In NSCLC - The IZA-A Trial

for Non-small Cell Lung Cancer

Drug: Adagrasib

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT07382726·Phase 1·Recruiting·Listed Feb 2026

Apply to this trial

52-week Open Label Safety-Tolerability Study

for Schizophrenia

Sites in Richardson, DeSoto +21 more locations

Sponsor: LB Pharmaceuticals Inc.

Sex: All·Age: 18 - 65

Code: NCT07369154·Phase 3·Recruiting·Listed Jan 2026

Apply to this trial

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

for Small Cell Lung Cancer

Sites in Houston, Tyler +30 more locations

Sponsor: AbbVie

Sex: All·Age: 18+

Code: NCT07365241·Phase 3·Recruiting·Listed Jan 2026

Apply to this trial

A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of Age

for Measles

Sites in Houston, Frisco +15 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 15 Months - 6·Accepts healthy volunteers

Code: NCT07406360·Phase 3·Recruiting·Listed Feb 2026

Apply to this trial

Snacks and Brain Health

for Cognitive Assessment

1 location in Lubbock

Sponsor: Texas Tech University Health Sciences Center

Sex: All·Age: 50+

Code: NCT07348406·Phase 1, Phase 2·Recruiting·Listed Jan 2026

Apply to this trial

A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment

for Moderate Hepatic Impairment

Sites in San Antonio +1 more location

Sponsor: AstraZeneca

Sex: All·Age: 18 - 80·Accepts healthy volunteers

Code: NCT07343960·Phase 1·Recruiting·Listed Jan 2026

Apply to this trial

A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult Participants With Lichen Sclerosus

for Lichen Sclerosus

Sites in Dallas +13 more locations

Sponsor: LEO Pharma

Sex: All·Age: 18+

Code: NCT07335588·Phase 3·Recruiting·Listed Jan 2026

Apply to this trial

Determine the Prevalence of Exocrine Pancreatic Insufficiency (EPI) in Pediatric and Adult Participants With Alagille Syndrome After Liver Transplantation

for Exocrine Pancreatic Insuficiency

Sites in El Paso +6 more locations

Sponsor: Digestive Care, Inc.

Sex: All·Age: 7 - 50

Code: NCT07335523·Recruiting·Listed Jan 2026

Apply to this trial

Evaluation of the Efficacy and Safety of Magnetic Resonance Angiography (MRA) Using Gadopiclenol Compared to Gadoterate Meglumine in the Assessment of Steno-occlusive Disease in Adult Patients With Suspected Vascular Disease

for Steno-occlusive Disease

Sites in Houston +5 more locations

Sponsor: Guerbet

Sex: All·Age: 18+

Code: NCT07348640·Phase 3·Recruiting·Listed Jan 2026

Apply to this trial

IS-001 Injection in Patients Undergoing Robotic-Assisted Colorectal Surgery

for Ureter Injury

Sites in Houston, Austin +7 more locations

Sponsor: Intuitive Surgical

Sex: All·Age: 16 - 75

Code: NCT07346066·Phase 3·Recruiting·Listed Jan 2026

Apply to this trial

A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors

for Thoracic Neoplasms, Lung Diseases, Small Cell Lung Carcinoma

Sites in Houston +3 more locations

Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.

Sex: All·Age: 18+

Code: NCT07407933·Phase 1, Phase 2·Recruiting·Listed Feb 2026

Apply to this trial

NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease

for Graves Disease

Sites in DeSoto, Webster +9 more locations

Sponsor: Merida Biosciences

Sex: All·Age: 18 - 65

Code: NCT07305818·Phase 1·Recruiting·Listed Dec 2025

Apply to this trial

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

for Non-small Cell Lung Cancer (NSCLC)

Sites in Austin, Plano +46 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07291037·Phase 3·Recruiting·Listed Dec 2025

Apply to this trial

VEL-101 to Prevent Rejection After Kidney Transplantation

for Transplantation, Kidney

1 location in Dallas

Sponsor: Veloxis Pharmaceuticals

Sex: All·Age: 18+

Code: NCT07290777·Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes

for Diabetes Mellitus, Type 2

Sites in Houston, Shavano Park +19 more locations

Sponsor: Novo Nordisk A/S

Sex: All·Age: 10 - 18

Code: NCT07282613·Phase 3·Recruiting·Listed Dec 2025

Apply to this trial

Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)

for Idiopathic Pulmonary Fibrosis (IPF)

Sites in The Woodlands, Webster +8 more locations

Sponsor: PureTech

Sex: All·Age: 40+

Code: NCT07284602·Phase 3·Recruiting·Listed Dec 2025

Apply to this trial

Phase 3 Trial of VMX-C001 vs Usual Pharmacological Care in Patients Taking a FXa Direct Oral Anticoagulant Who Require Urgent Surgery With or Without Heparin.

for Blood Loss, Surgical

Sites in Houston, El Paso +15 more locations

Sponsor: VarmX B.V.

Sex: All·Age: 18+

Code: NCT07288489·Phase 3·Recruiting·Listed Dec 2025

Apply to this trial

A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma

for Eosinophilic Asthma

Sites in Dallas, McKinney +32 more locations

Sponsor: Kymera Therapeutics, Inc.

Sex: All·Age: 18 - 75

Code: NCT07323654·Phase 2·Recruiting·Listed Jan 2026

Apply to this trial

LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

for Pulmonary Hypertension Associated With HFpEF

Sites in Houston, Dallas +43 more locations

Sponsor: Tenax Therapeutics, Inc.

Sex: All·Age: 18 - 85

Code: NCT07288398·Phase 3·Recruiting·Listed Dec 2025

Apply to this trial

Deucravacitinib-TNFi Combination Therapy for Difficult-to-Control Psoriatic Disease

for Psoriatic Arthritis (PsA)

Drug: Deucravacitinib

1 location in Dallas

Sponsor: University of Texas Southwestern Medical Center

Sex: All·Age: 18 - 65

Code: NCT07280702·Phase 4·Recruiting·Listed Dec 2025

Apply to this trial

A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use

for Nausea and Vomiting

Sites in San Antonio, Plano +8 more locations

Sponsor: Vanda Pharmaceuticals

Sex: All·Age: 18 - 65·Accepts healthy volunteers

Code: NCT07446439·Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults

for Asthma

Sites in McKinney +17 more locations

Sponsor: Enveda Therapeutics

Sex: All·Age: 18 - 75

Code: NCT07301255·Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

for Atopic Dermatitis (AD)

Sites in Houston, San Antonio +30 more locations

Sponsor: Enveda Therapeutics

Sex: All·Age: 18 - 75

Code: NCT07298395·Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies

for Neoplasms

Drug: Nivolumab

Sites in San Antonio +4 more locations

Sponsor: Corcept Therapeutics

Sex: All·Age: 18+

Code: NCT07276373·Phase 1, Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase

for Chronic Myeloid Leukemia

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT07269470·Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

A Study of Efimosfermin Alfa in Adults With Hepatic Impairment

for Non-alcoholic Fatty Liver Disease

Sites in San Antonio +2 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 18 - 70

Code: NCT07358546·Phase 1·Recruiting·Listed Jan 2026

Apply to this trial